Targeting the nicotinic acetylcholine receptors (nAChRs) in astrocytes as a potential therapeutic target in Parkinson’s disease

dc.creatorJurado-Coronel J.C.
dc.creatorÁvila-Rodriguez M.
dc.creatorCapani F.
dc.creatorGonzalez J.
dc.creatorMorán V.E.
dc.creatorBarreto G.E.
dc.date.accessioned2020-09-02T22:21:03Z
dc.date.accessioned2022-11-08T20:20:04Z
dc.date.available2020-09-02T22:21:03Z
dc.date.available2022-11-08T20:20:04Z
dc.date.created2020-09-02T22:21:03Z
dc.date.issued2016
dc.identifier22, 10, 1305-1311
dc.identifier13816128
dc.identifierhttps://hdl.handle.net/20.500.12728/4987
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/5143440
dc.languageen
dc.publisherBentham Science Publishers
dc.subjectApoptosis
dc.subjectAstrocytes
dc.subjectnAChRs
dc.subjectNeuroinflammation
dc.subjectNeuroprotection
dc.subjectNicotine
dc.subjectParkinson disease
dc.subjectnicotine
dc.subjectnicotinic receptor
dc.subjectneuroprotective agent
dc.subjectnicotinic receptor
dc.subjectapoptosis
dc.subjectArticle
dc.subjectastrocyte
dc.subjectcell activation
dc.subjectcognitive defect
dc.subjectdisability
dc.subjectdisease course
dc.subjectdopaminergic nerve cell
dc.subjectdrug mechanism
dc.subjectgait disorder
dc.subjectglia cell
dc.subjecthuman
dc.subjectimmune response
dc.subjectin vitro study
dc.subjectin vivo study
dc.subjectmuscle rigidity
dc.subjectnerve cell plasticity
dc.subjectnervous system inflammation
dc.subjectneuroprotection
dc.subjectnonhuman
dc.subjectParkinson disease
dc.subjectpriority journal
dc.subjectprotein expression
dc.subjectprotein targeting
dc.subjectquality of life
dc.subjectsubstantia nigra pars compacta
dc.subjecttremor
dc.subjectanimal
dc.subjectastrocyte
dc.subjectchemistry
dc.subjectdrug effects
dc.subjectmetabolism
dc.subjectParkinson disease
dc.subjectpathology
dc.subjectAnimals
dc.subjectAstrocytes
dc.subjectHumans
dc.subjectNeuroprotective Agents
dc.subjectParkinson Disease
dc.subjectReceptors, Nicotinic
dc.titleTargeting the nicotinic acetylcholine receptors (nAChRs) in astrocytes as a potential therapeutic target in Parkinson’s disease
dc.typeArticle


Este ítem pertenece a la siguiente institución